Novartis bets on bigger blockbusters to power growth, forecasting 5% annual sales through 2031
The drugmaker cited strong demand for its blockbuster drugs as it upgraded peak sales forecasts for multiple sclerosis, leukemia, and cholesterol medicines.
We haven't written up this one. CNBC World has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- Novartis forecasts 5% annual sales growth through 2031 investing.com